香港股市 已收市

Invitae Corporation (0JDB.L)

LSE - LSE 延遲價格。貨幣為 USD。
加入追蹤清單
0.0117-0.0013 (-10.00%)
市場開市。 截至 06:50PM GMT。
全螢幕
前收市價0.0130
開市0.0000
買盤0.0000 x 0
賣出價0.0000 x 0
今日波幅0.0000 - 0.0000
52 週波幅
成交量0
平均成交量225,013
市值10,677
Beta 值 (5 年,每月)1.30
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-2.0560
業績公佈日2024年5月07日 - 2024年5月13日
遠期股息及收益率無 (無)
除息日
1 年預測目標價
  • Benzinga

    SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy

    Invitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on the brink of filing for bankruptcy in the coming weeks. The San Francisco-based medical genetics company, grappling with a substantial $1.5 billion debt burden, is enlisting the expertise of restructuring advisers from FTI Consulting and legal counsel from Kirkland & Ellis to navigate its financial challenges. Amidst this financial turmoil, Invitae is actively exploring various strategic options,

  • Motley Fool

    Is Invitae Stock a Buy Now?

    Invitae shares have lost more than 80% over the past year and a half.

  • InvestorPlace

    3 Cathie Wood Stocks to Sell Before It’s Too Late

    The allure of Cathie Wood Stocks investing prowess has captured a large audience of investors. Yet, even amidst all of the optimism surrounding her investment strategies, prudent investors must be aware of the potential downside risks. While some of Cathie Wood’s early bets like Tesla have paid off, many of them have lost her clients a ton of money. However, there are some Cathie Wood Stocks to sell, and these. aresome of them. Some investors may argue that her bets on revolutionary technologies